# Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge Strain

> **NCT05572450** · NA · COMPLETED · sponsor: **Hvivo** · enrollment: 70 (actual)

## Conditions studied

- Influenza A H1N1

## Interventions

- **OTHER:** Infectious Titre 1
- **OTHER:** Infectious Titre 2
- **OTHER:** Infectious Titre 3
- **OTHER:** Infectious Titre 4

## Key facts

- **NCT ID:** NCT05572450
- **Lead sponsor:** Hvivo
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-07
- **Primary completion:** 2022-12-19
- **Final completion:** 2022-12-19
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2023-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05572450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05572450, "Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge Strain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05572450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*